- Published on 04 January 2021
Newly published research from Tel Aviv University (TAU) found no evidence of damage to the auditory system from the Covid-19 disease, although the study sample was small and involved only asymptomatic patients.
- Published on 31 December 2020
Mouse model research in Israel has raised hopes of a successful gene therapy for the one in approximately 2,000 children born with a gene mutation that causes deafness.
- Published on 24 December 2020
Work towards a pharmacological solution for tinnitus has been recognised by the British Tinnitus Association (BTA) conferring its top annual award—the Marie and Jack Shapiro Prize—to a study that investigated the safety and efficacy of a potential drug treatment for the condition.
Biomarkers project awarded 50% chunk of the British Tinnitus Association’s biggest ever funding round
- Published on 12 December 2020
A King’s College London study that aims to identify tinnitus biomarkers has been granted £125k in funding by the UK charity, the British Tinnitus Association (BTA).
- Published on 07 December 2020
An early diagnosis system using gene mutation analysis has been successfully tested by the University Clinic of Navarra (UNAV) in Spain, as well as several laboratories and hospitals in Spain, Portugal and France.
- Published on 04 December 2020
The growing informational and material resources offered to researchers by biobanks could help bring game-changing discoveries in hearing, even cures. And research into tinnitus is just one area that can potentially benefit from these data collections as their focus on hearing becomes broader.
- Published on 23 November 2020
Early non-verbal communication skills involving gestural behaviour can be severely impacted by infant deafness, reveals new research by psychologists at the University of Sheffield, UK.
- Published on 21 November 2020
An algorithm developed by researchers at the Bionics Institute in Melbourne, Australia may pave the way to providing a tool for clinicians to detect and objectively measure a patient’s tinnitus.
- Published on 18 November 2020
Market approval may still be several years away for a totally implantable cochlear implant (CI), but the Austrian hearing tech firm MED-EL is currently performing its first surgeries in this direction with the project at the clinical feasibility study stage.
- Published on 17 November 2020
Developing some kind of narrative around hearing technology is a must for all manufacturers, but the Demant group digs deep into the subsoil of science with the BrainHearing framework it has built around its Oticon brand devices.